Trial intelligence / Profile preview

Bevonescein for Improved Intraoperative Nerve Visualization in Thyroidectomy

NCT07631650Phase 2Recruiting

Start
Oct 2026
Primary completion
Aug 2027
Countries
1
01

Overview

A Phase 2 trial of bevonescein in head and neck disorders (H&N), head and neck cancer (HNC). Started Oct 2026; status: recruiting.

02

Drugs

bevonescein
03

Conditions

head and neck disorders (H&N)head and neck cancer (HNC)

Beyond the preview

Go deeper on NCT07631650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07631650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call